Biomarkers of oxidative damage in cigarette smokers: Which biomarkers might reflect acute versus chronic oxidative stress?

Cigarette smoking predisposes to the development of multiple diseases involving oxidative damage. We measured a range of oxidative damage biomarkers to understand which differ between smokers and nonsmokers and if the levels of these biomarkers change further during the act of smoking itself. Despit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Free radical biology & medicine 2011-06, Vol.50 (12), p.1787-1793
Hauptverfasser: Seet, Raymond C.S., Lee, Chung-Yung J., Loke, Wai Mun, Huang, Shan Hong, Huang, Huiwen, Looi, Woan Foon, Chew, Eng Soh, Quek, Amy M.L., Lim, Erle C.H., Halliwell, Barry
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1793
container_issue 12
container_start_page 1787
container_title Free radical biology & medicine
container_volume 50
creator Seet, Raymond C.S.
Lee, Chung-Yung J.
Loke, Wai Mun
Huang, Shan Hong
Huang, Huiwen
Looi, Woan Foon
Chew, Eng Soh
Quek, Amy M.L.
Lim, Erle C.H.
Halliwell, Barry
description Cigarette smoking predisposes to the development of multiple diseases involving oxidative damage. We measured a range of oxidative damage biomarkers to understand which differ between smokers and nonsmokers and if the levels of these biomarkers change further during the act of smoking itself. Despite overnight abstinence from smoking, smokers had higher levels of plasma total and esterified F2-isoprostanes, hydroxyeicosatetraenoic acid products (HETEs), F4-neuroprostanes, 7-ketocholesterol, and 24- and 27-hydroxycholesterol. Levels of urinary F2-isoprostanes, HETEs, and 8-hydroxy-2′-deoxyguanosine were also increased compared with age-matched nonsmokers. Several biomarkers (plasma free F2-isoprostanes, allantoin, and 7β-hydroxycholesterol and urinary F2-isoprostane metabolites) were not elevated. The smokers were then asked to smoke a cigarette; this acute smoking elevated plasma and urinary F2-isoprostanes, plasma allantoin, and certain cholesterol oxidation products compared to presmoking levels, but not plasma HETEs or urinary 8-hydroxy-2′-deoxyguanosine. Smokers showed differences in plasma fatty acid composition. Our findings confirm that certain oxidative damage biomarkers are elevated in smokers even after a period of abstinence from smoking, whereas these plus some others are elevated after acute smoking. Thus, different biomarkers do not measure identical aspects of oxidative stress.
doi_str_mv 10.1016/j.freeradbiomed.2011.03.019
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_867481209</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0891584911001766</els_id><sourcerecordid>867481209</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-ebd69beeaa476e64bb698762f1bff6ced589f32f9ac479e083cffdae9f5b2b3e3</originalsourceid><addsrcrecordid>eNqNkU9v1DAQxS0EokvhK4AlDnBJGMeOE8MBQVX-SJU4QMXRsp3xrpfNutjJCvj0OGwr4II4-TC_98bzHiGPGdQMmHy2rX1CTGawIY441A0wVgOvgalbZMX6jleiVfI2WUGvWNX2Qp2QezlvAUC0vL9LThomGhAKVuTH62Ji0hdMmUZP47cwmCkckA5mNGukYU9dWJuE04Q0j3EBn9PPm-A21P6WjmG9mWhCv0M3UePmQh_KYM7UbVLcB_eHdZ4S5vzyPrnjzS7jg-v3lFy-Of909q66-PD2_dmri8oJrqYK7SCVRTRGdBKlsFaqvpONZ9Z76XBoe-V545VxolMIPXfeDwaVb21jOfJT8uToe5Xi1xnzpMeQHe52Zo9xzrqXnehZA6qQT_9JMlkWSwG_0BdH1KWYczlcX6VQ0viuGeilJr3Vf9Wkl5o0cF1qKuqH14tmu8xutDe9FODREfAmarNOIevLj8WhBWBcCrVYnB8JLNEdAiadXcB9ySOk0oEeYvivr_wEp8C4eA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1687664009</pqid></control><display><type>article</type><title>Biomarkers of oxidative damage in cigarette smokers: Which biomarkers might reflect acute versus chronic oxidative stress?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Seet, Raymond C.S. ; Lee, Chung-Yung J. ; Loke, Wai Mun ; Huang, Shan Hong ; Huang, Huiwen ; Looi, Woan Foon ; Chew, Eng Soh ; Quek, Amy M.L. ; Lim, Erle C.H. ; Halliwell, Barry</creator><creatorcontrib>Seet, Raymond C.S. ; Lee, Chung-Yung J. ; Loke, Wai Mun ; Huang, Shan Hong ; Huang, Huiwen ; Looi, Woan Foon ; Chew, Eng Soh ; Quek, Amy M.L. ; Lim, Erle C.H. ; Halliwell, Barry</creatorcontrib><description>Cigarette smoking predisposes to the development of multiple diseases involving oxidative damage. We measured a range of oxidative damage biomarkers to understand which differ between smokers and nonsmokers and if the levels of these biomarkers change further during the act of smoking itself. Despite overnight abstinence from smoking, smokers had higher levels of plasma total and esterified F2-isoprostanes, hydroxyeicosatetraenoic acid products (HETEs), F4-neuroprostanes, 7-ketocholesterol, and 24- and 27-hydroxycholesterol. Levels of urinary F2-isoprostanes, HETEs, and 8-hydroxy-2′-deoxyguanosine were also increased compared with age-matched nonsmokers. Several biomarkers (plasma free F2-isoprostanes, allantoin, and 7β-hydroxycholesterol and urinary F2-isoprostane metabolites) were not elevated. The smokers were then asked to smoke a cigarette; this acute smoking elevated plasma and urinary F2-isoprostanes, plasma allantoin, and certain cholesterol oxidation products compared to presmoking levels, but not plasma HETEs or urinary 8-hydroxy-2′-deoxyguanosine. Smokers showed differences in plasma fatty acid composition. Our findings confirm that certain oxidative damage biomarkers are elevated in smokers even after a period of abstinence from smoking, whereas these plus some others are elevated after acute smoking. Thus, different biomarkers do not measure identical aspects of oxidative stress.</description><identifier>ISSN: 0891-5849</identifier><identifier>EISSN: 1873-4596</identifier><identifier>DOI: 10.1016/j.freeradbiomed.2011.03.019</identifier><identifier>PMID: 21420490</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; allantoin ; Allantoin - blood ; biomarkers ; Biomarkers - blood ; Biomarkers - urine ; cholesterol ; Cholesterol oxidation products ; Cigarette smoking ; cigarettes ; Deoxyguanosine - analogs &amp; derivatives ; Deoxyguanosine - metabolism ; Deoxyguanosine - urine ; esterification ; F2-Isoprostanes - blood ; F2-Isoprostanes - metabolism ; F2-Isoprostanes - urine ; fatty acid composition ; Free Radicals ; Humans ; Hydroxycholesterols - blood ; Hydroxycholesterols - metabolism ; Hydroxyeicosatetraenoic acid products ; Hydroxyeicosatetraenoic Acids - blood ; Hydroxyeicosatetraenoic Acids - metabolism ; Hydroxyeicosatetraenoic Acids - urine ; Isoprostanes ; Ketocholesterols - blood ; Ketocholesterols - metabolism ; Male ; metabolites ; Middle Aged ; oxidation ; Oxidative Stress ; smoking (habit) ; Smoking - blood ; Smoking - metabolism ; Smoking - urine</subject><ispartof>Free radical biology &amp; medicine, 2011-06, Vol.50 (12), p.1787-1793</ispartof><rights>2011 Elsevier Inc.</rights><rights>Copyright © 2011 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-ebd69beeaa476e64bb698762f1bff6ced589f32f9ac479e083cffdae9f5b2b3e3</citedby><cites>FETCH-LOGICAL-c439t-ebd69beeaa476e64bb698762f1bff6ced589f32f9ac479e083cffdae9f5b2b3e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0891584911001766$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21420490$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Seet, Raymond C.S.</creatorcontrib><creatorcontrib>Lee, Chung-Yung J.</creatorcontrib><creatorcontrib>Loke, Wai Mun</creatorcontrib><creatorcontrib>Huang, Shan Hong</creatorcontrib><creatorcontrib>Huang, Huiwen</creatorcontrib><creatorcontrib>Looi, Woan Foon</creatorcontrib><creatorcontrib>Chew, Eng Soh</creatorcontrib><creatorcontrib>Quek, Amy M.L.</creatorcontrib><creatorcontrib>Lim, Erle C.H.</creatorcontrib><creatorcontrib>Halliwell, Barry</creatorcontrib><title>Biomarkers of oxidative damage in cigarette smokers: Which biomarkers might reflect acute versus chronic oxidative stress?</title><title>Free radical biology &amp; medicine</title><addtitle>Free Radic Biol Med</addtitle><description>Cigarette smoking predisposes to the development of multiple diseases involving oxidative damage. We measured a range of oxidative damage biomarkers to understand which differ between smokers and nonsmokers and if the levels of these biomarkers change further during the act of smoking itself. Despite overnight abstinence from smoking, smokers had higher levels of plasma total and esterified F2-isoprostanes, hydroxyeicosatetraenoic acid products (HETEs), F4-neuroprostanes, 7-ketocholesterol, and 24- and 27-hydroxycholesterol. Levels of urinary F2-isoprostanes, HETEs, and 8-hydroxy-2′-deoxyguanosine were also increased compared with age-matched nonsmokers. Several biomarkers (plasma free F2-isoprostanes, allantoin, and 7β-hydroxycholesterol and urinary F2-isoprostane metabolites) were not elevated. The smokers were then asked to smoke a cigarette; this acute smoking elevated plasma and urinary F2-isoprostanes, plasma allantoin, and certain cholesterol oxidation products compared to presmoking levels, but not plasma HETEs or urinary 8-hydroxy-2′-deoxyguanosine. Smokers showed differences in plasma fatty acid composition. Our findings confirm that certain oxidative damage biomarkers are elevated in smokers even after a period of abstinence from smoking, whereas these plus some others are elevated after acute smoking. Thus, different biomarkers do not measure identical aspects of oxidative stress.</description><subject>Adult</subject><subject>Aged</subject><subject>allantoin</subject><subject>Allantoin - blood</subject><subject>biomarkers</subject><subject>Biomarkers - blood</subject><subject>Biomarkers - urine</subject><subject>cholesterol</subject><subject>Cholesterol oxidation products</subject><subject>Cigarette smoking</subject><subject>cigarettes</subject><subject>Deoxyguanosine - analogs &amp; derivatives</subject><subject>Deoxyguanosine - metabolism</subject><subject>Deoxyguanosine - urine</subject><subject>esterification</subject><subject>F2-Isoprostanes - blood</subject><subject>F2-Isoprostanes - metabolism</subject><subject>F2-Isoprostanes - urine</subject><subject>fatty acid composition</subject><subject>Free Radicals</subject><subject>Humans</subject><subject>Hydroxycholesterols - blood</subject><subject>Hydroxycholesterols - metabolism</subject><subject>Hydroxyeicosatetraenoic acid products</subject><subject>Hydroxyeicosatetraenoic Acids - blood</subject><subject>Hydroxyeicosatetraenoic Acids - metabolism</subject><subject>Hydroxyeicosatetraenoic Acids - urine</subject><subject>Isoprostanes</subject><subject>Ketocholesterols - blood</subject><subject>Ketocholesterols - metabolism</subject><subject>Male</subject><subject>metabolites</subject><subject>Middle Aged</subject><subject>oxidation</subject><subject>Oxidative Stress</subject><subject>smoking (habit)</subject><subject>Smoking - blood</subject><subject>Smoking - metabolism</subject><subject>Smoking - urine</subject><issn>0891-5849</issn><issn>1873-4596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU9v1DAQxS0EokvhK4AlDnBJGMeOE8MBQVX-SJU4QMXRsp3xrpfNutjJCvj0OGwr4II4-TC_98bzHiGPGdQMmHy2rX1CTGawIY441A0wVgOvgalbZMX6jleiVfI2WUGvWNX2Qp2QezlvAUC0vL9LThomGhAKVuTH62Ji0hdMmUZP47cwmCkckA5mNGukYU9dWJuE04Q0j3EBn9PPm-A21P6WjmG9mWhCv0M3UePmQh_KYM7UbVLcB_eHdZ4S5vzyPrnjzS7jg-v3lFy-Of909q66-PD2_dmri8oJrqYK7SCVRTRGdBKlsFaqvpONZ9Z76XBoe-V545VxolMIPXfeDwaVb21jOfJT8uToe5Xi1xnzpMeQHe52Zo9xzrqXnehZA6qQT_9JMlkWSwG_0BdH1KWYczlcX6VQ0viuGeilJr3Vf9Wkl5o0cF1qKuqH14tmu8xutDe9FODREfAmarNOIevLj8WhBWBcCrVYnB8JLNEdAiadXcB9ySOk0oEeYvivr_wEp8C4eA</recordid><startdate>20110615</startdate><enddate>20110615</enddate><creator>Seet, Raymond C.S.</creator><creator>Lee, Chung-Yung J.</creator><creator>Loke, Wai Mun</creator><creator>Huang, Shan Hong</creator><creator>Huang, Huiwen</creator><creator>Looi, Woan Foon</creator><creator>Chew, Eng Soh</creator><creator>Quek, Amy M.L.</creator><creator>Lim, Erle C.H.</creator><creator>Halliwell, Barry</creator><general>Elsevier Inc</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20110615</creationdate><title>Biomarkers of oxidative damage in cigarette smokers: Which biomarkers might reflect acute versus chronic oxidative stress?</title><author>Seet, Raymond C.S. ; Lee, Chung-Yung J. ; Loke, Wai Mun ; Huang, Shan Hong ; Huang, Huiwen ; Looi, Woan Foon ; Chew, Eng Soh ; Quek, Amy M.L. ; Lim, Erle C.H. ; Halliwell, Barry</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-ebd69beeaa476e64bb698762f1bff6ced589f32f9ac479e083cffdae9f5b2b3e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Aged</topic><topic>allantoin</topic><topic>Allantoin - blood</topic><topic>biomarkers</topic><topic>Biomarkers - blood</topic><topic>Biomarkers - urine</topic><topic>cholesterol</topic><topic>Cholesterol oxidation products</topic><topic>Cigarette smoking</topic><topic>cigarettes</topic><topic>Deoxyguanosine - analogs &amp; derivatives</topic><topic>Deoxyguanosine - metabolism</topic><topic>Deoxyguanosine - urine</topic><topic>esterification</topic><topic>F2-Isoprostanes - blood</topic><topic>F2-Isoprostanes - metabolism</topic><topic>F2-Isoprostanes - urine</topic><topic>fatty acid composition</topic><topic>Free Radicals</topic><topic>Humans</topic><topic>Hydroxycholesterols - blood</topic><topic>Hydroxycholesterols - metabolism</topic><topic>Hydroxyeicosatetraenoic acid products</topic><topic>Hydroxyeicosatetraenoic Acids - blood</topic><topic>Hydroxyeicosatetraenoic Acids - metabolism</topic><topic>Hydroxyeicosatetraenoic Acids - urine</topic><topic>Isoprostanes</topic><topic>Ketocholesterols - blood</topic><topic>Ketocholesterols - metabolism</topic><topic>Male</topic><topic>metabolites</topic><topic>Middle Aged</topic><topic>oxidation</topic><topic>Oxidative Stress</topic><topic>smoking (habit)</topic><topic>Smoking - blood</topic><topic>Smoking - metabolism</topic><topic>Smoking - urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Seet, Raymond C.S.</creatorcontrib><creatorcontrib>Lee, Chung-Yung J.</creatorcontrib><creatorcontrib>Loke, Wai Mun</creatorcontrib><creatorcontrib>Huang, Shan Hong</creatorcontrib><creatorcontrib>Huang, Huiwen</creatorcontrib><creatorcontrib>Looi, Woan Foon</creatorcontrib><creatorcontrib>Chew, Eng Soh</creatorcontrib><creatorcontrib>Quek, Amy M.L.</creatorcontrib><creatorcontrib>Lim, Erle C.H.</creatorcontrib><creatorcontrib>Halliwell, Barry</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Free radical biology &amp; medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Seet, Raymond C.S.</au><au>Lee, Chung-Yung J.</au><au>Loke, Wai Mun</au><au>Huang, Shan Hong</au><au>Huang, Huiwen</au><au>Looi, Woan Foon</au><au>Chew, Eng Soh</au><au>Quek, Amy M.L.</au><au>Lim, Erle C.H.</au><au>Halliwell, Barry</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biomarkers of oxidative damage in cigarette smokers: Which biomarkers might reflect acute versus chronic oxidative stress?</atitle><jtitle>Free radical biology &amp; medicine</jtitle><addtitle>Free Radic Biol Med</addtitle><date>2011-06-15</date><risdate>2011</risdate><volume>50</volume><issue>12</issue><spage>1787</spage><epage>1793</epage><pages>1787-1793</pages><issn>0891-5849</issn><eissn>1873-4596</eissn><abstract>Cigarette smoking predisposes to the development of multiple diseases involving oxidative damage. We measured a range of oxidative damage biomarkers to understand which differ between smokers and nonsmokers and if the levels of these biomarkers change further during the act of smoking itself. Despite overnight abstinence from smoking, smokers had higher levels of plasma total and esterified F2-isoprostanes, hydroxyeicosatetraenoic acid products (HETEs), F4-neuroprostanes, 7-ketocholesterol, and 24- and 27-hydroxycholesterol. Levels of urinary F2-isoprostanes, HETEs, and 8-hydroxy-2′-deoxyguanosine were also increased compared with age-matched nonsmokers. Several biomarkers (plasma free F2-isoprostanes, allantoin, and 7β-hydroxycholesterol and urinary F2-isoprostane metabolites) were not elevated. The smokers were then asked to smoke a cigarette; this acute smoking elevated plasma and urinary F2-isoprostanes, plasma allantoin, and certain cholesterol oxidation products compared to presmoking levels, but not plasma HETEs or urinary 8-hydroxy-2′-deoxyguanosine. Smokers showed differences in plasma fatty acid composition. Our findings confirm that certain oxidative damage biomarkers are elevated in smokers even after a period of abstinence from smoking, whereas these plus some others are elevated after acute smoking. Thus, different biomarkers do not measure identical aspects of oxidative stress.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>21420490</pmid><doi>10.1016/j.freeradbiomed.2011.03.019</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0891-5849
ispartof Free radical biology & medicine, 2011-06, Vol.50 (12), p.1787-1793
issn 0891-5849
1873-4596
language eng
recordid cdi_proquest_miscellaneous_867481209
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Aged
allantoin
Allantoin - blood
biomarkers
Biomarkers - blood
Biomarkers - urine
cholesterol
Cholesterol oxidation products
Cigarette smoking
cigarettes
Deoxyguanosine - analogs & derivatives
Deoxyguanosine - metabolism
Deoxyguanosine - urine
esterification
F2-Isoprostanes - blood
F2-Isoprostanes - metabolism
F2-Isoprostanes - urine
fatty acid composition
Free Radicals
Humans
Hydroxycholesterols - blood
Hydroxycholesterols - metabolism
Hydroxyeicosatetraenoic acid products
Hydroxyeicosatetraenoic Acids - blood
Hydroxyeicosatetraenoic Acids - metabolism
Hydroxyeicosatetraenoic Acids - urine
Isoprostanes
Ketocholesterols - blood
Ketocholesterols - metabolism
Male
metabolites
Middle Aged
oxidation
Oxidative Stress
smoking (habit)
Smoking - blood
Smoking - metabolism
Smoking - urine
title Biomarkers of oxidative damage in cigarette smokers: Which biomarkers might reflect acute versus chronic oxidative stress?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T14%3A45%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biomarkers%20of%20oxidative%20damage%20in%20cigarette%20smokers:%20Which%20biomarkers%20might%20reflect%20acute%20versus%20chronic%20oxidative%20stress?&rft.jtitle=Free%20radical%20biology%20&%20medicine&rft.au=Seet,%20Raymond%20C.S.&rft.date=2011-06-15&rft.volume=50&rft.issue=12&rft.spage=1787&rft.epage=1793&rft.pages=1787-1793&rft.issn=0891-5849&rft.eissn=1873-4596&rft_id=info:doi/10.1016/j.freeradbiomed.2011.03.019&rft_dat=%3Cproquest_cross%3E867481209%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1687664009&rft_id=info:pmid/21420490&rft_els_id=S0891584911001766&rfr_iscdi=true